What is step therapy with Calibrate?

At the initial clinician appointment, members are provided with the best treatment plan based on their risk profile. This may include participating in at least 90 days of the Calibrate Intensive Lifestyle Program (ILI) before starting GLP-1 medication.

During the 90-day ILI period, members must engage with the curriculum, attend coaching appointments, and track their progress in the Calibrate app.

After 90 days, the decision to start GLP-1 medication is then made as a shared decision between the member and their clinician, taking into account BMI, medical history, progress, co-morbidities, family history, and other risk factors. If a member meets the disengagement criteria at any point during the program, the disenrollment process will be initiated.